scholarly article | Q13442814 |
P356 | DOI | 10.1038/KI.1993.171 |
P698 | PubMed publication ID | 8391095 |
P2093 | author name string | G L Bakris | |
S A Brown | |||
P Crawford | |||
C L Walton | |||
P2860 | cites work | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
Effects of different calcium antagonists on proteinuria associated with diabetes mellitus | Q28332014 | ||
Structural-functional relationships in diabetic nephropathy | Q34616152 | ||
Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension | Q36994591 | ||
Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions | Q38219012 | ||
Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. | Q39912935 | ||
The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies | Q40325056 | ||
Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection | Q41085449 | ||
Long-term renal responses to high dietary protein in dogs with 75% nephrectomy | Q41468209 | ||
Determinants of glomerular filtration rate in the dog. | Q45051664 | ||
Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics | Q47283500 | ||
Diabetic nephropathy in the uninephrectomized dog: microscopic lesions after one year. | Q51651028 | ||
Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. | Q54136807 | ||
Studies of renal autoregulation in pancreatectomized and streptozotocin diabetic rats. | Q54328960 | ||
Evaluation of the single nephron glomerular filtration coefficient in the dog. | Q54595045 | ||
Glomerular filtration dynamics in the dog during elevated plasma colloid osmotic pressure | Q66928686 | ||
Nifedipine versus fosinopril in uninephrectomized diabetic rats | Q67547021 | ||
Angiotensin converting enzyme inhibitors versus calcium antagonists in the treatment of diabetic hypertensive patients | Q67743549 | ||
Familial Clustering of Cardiovascular Disease in Patients with Insulin-Dependent Diabetes and Nephropathy | Q67745344 | ||
Dietary protein intake and the glomerular adaptations to partial nephrectomy in dogs | Q68043953 | ||
Renal hemodynamic effects of calcium antagonists in rats with reduced renal mass | Q68206364 | ||
Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus | Q68458135 | ||
Glomerular filtration surface in type I diabetes mellitus | Q69520806 | ||
Autoregulation of renal blood flow in streptozocin-induced diabetic rats | Q69530145 | ||
Short and long term effects of antihypertensive therapy in the diabetic rat | Q69551221 | ||
The contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor | Q69835751 | ||
Effects of calcium channel blockade on renal vascular resistance responses to changes in perfusion pressure and angiotensin-converting enzyme inhibition in dogs | Q70142030 | ||
Comparison of directly measured and calculated glomerular capillary pressure in the dog kidney at varying perfusion pressure | Q70651230 | ||
Glomerular hemodynamics in experimental diabetes mellitus | Q70801958 | ||
Influence of converting enzyme inhibition on renal hemodynamics and glomerular dynamics in sodium-restricted dogs | Q72659482 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hemodynamics | Q1642137 |
P304 | page(s) | 1210-1218 | |
P577 | publication date | 1993-06-01 | |
P1433 | published in | Kidney International | Q6404823 |
P1476 | title | Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuria | |
P478 | volume | 43 |
Q57792989 | ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats |
Q36100656 | Amlodipine Reduces Inflammation despite Promoting Albuminuria in the Streptozotocin-Induced Diabetic Rat |
Q34633316 | Angiotensin converting enzyme inhibitors or angiotensin receptor blockers in nephropathy from type 2 diabetes |
Q74597349 | Beneficial effects of chronic administration of dietary omega-3 polyunsaturated fatty acids in dogs with renal insufficiency |
Q33917790 | Calcium channel blockers - the effect on renal changes in clinical and experimental diabetes: an overview |
Q41527666 | Can we further slow down the progression to end-stage renal disease in diabetic hypertensive patients? |
Q70804080 | Canine and equine mesangial cells in vitro |
Q34784142 | Chronic sodium-retaining action of insulin in diabetic dogs |
Q36974761 | Comparison between Urine Protein: Creatinine Ratios of Samples Obtained from Dogs in Home and Hospital Settings |
Q41530033 | Cost containment for treating hypertension in African Americans: impact of a combined ACE inhibitor-calcium channel blocker |
Q41094725 | Diabetic vascular injury and ACE. Potential for pharmacological prevention of complications of later life |
Q33546807 | Diagnosis and treatment of systemic hypertension |
Q41204656 | Does modifying dietary lipids influence the progression of renal failure? |
Q72735542 | Effects of different antihypertensive treatments on morphologic progression of diabetic nephropathy in uninephrectomized dogs |
Q36975222 | Evaluation of the effects of a therapeutic renal diet to control proteinuria in proteinuric non-azotemic dogs treated with benazepril |
Q74151922 | Influence of the timing of initiating antihypertensive therapy in hypertensive rats with renal failure |
Q77644328 | Interventional nutrition for renal disease |
Q40474410 | Long-term complications of diabetes mellitus, Part I: Retinopathy, nephropathy, neuropathy. |
Q36873449 | Longitudinal prevalence of hypertension, proteinuria, and retinopathy in dogs with spontaneous diabetes mellitus |
Q41600492 | Pathophysiology and management of progressive renal disease |
Q41640622 | Predictors of renal and cardiovascular mortality in patients with non-insulin-dependent diabetes: a brief overview of microalbuminuria and insulin resistance |
Q47897430 | Prognosis of diabetic nephropathy: how to improve the outcome |
Q74741271 | Progression of diabetic nephropathy. A focus on arterial pressure level and methods of reduction |
Q74080676 | Renal effects of antihypertensive therapy in uninephrectomized diabetic rats |
Q41431044 | Renal mortality associated with non-insulin-dependent diabetes mellitus |
Q33649627 | Renal protection and antihypertensive drugs: current status |
Q46426114 | Renin-angiotensin blockade and kidney disease |
Q36679313 | Salt, hypertension and renal disease: comparative medicine, models and real diseases |
Q41625037 | Systemic hypertension and its management |
Q44514327 | The BErgamo NEphrologic DIabetes Complications Trial (BENEDICT): design and baseline characteristics |
Q74299128 | The case for combining angiotensin-converting enzyme inhibitors and calcium-channel blockers |
Q36680739 | The diabetic patient with hypertension |
Q64101852 | The renin-angiotensin-aldosterone system and its suppression |
Q34454208 | Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme (ACE) inhibitor |
Search more.